Larson Financial Group’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.07K | Sell |
166
-747
| -82% | -$17.7K | ﹤0.01% | 2696 |
|
|
2025
Q4 | $22.7K | Buy |
913
+478
| +110% | +$12.7K | ﹤0.01% | 1643 |
|
|
2025
Q3 | $12.3K | Buy |
435
+346
| +389% | +$9.38K | ﹤0.01% | 1910 |
|
|
2025
Q2 | $2.21K | Sell |
89
-2
| -2% | -$56 | ﹤0.01% | 2371 |
|
|
2025
Q1 | $2.82K | Hold |
91
| – | – | ﹤0.01% | 2057 |
|
|
2024
Q4 | $2.87K | Hold |
91
| – | – | ﹤0.01% | 1800 |
|
|
2024
Q3 | $5.27K | Hold |
91
| – | – | ﹤0.01% | 1662 |
|
|
2024
Q2 | $3.69K | Buy |
91
+6
| +7% | +$238 | ﹤0.01% | 1502 |
|
|
2024
Q1 | $3.57K | Hold |
85
| – | – | ﹤0.01% | 1260 |
|
|
2023
Q4 | $3.26K | Hold |
85
| – | – | ﹤0.01% | 1280 |
|
|
2023
Q3 | $2.62K | Hold |
85
| – | – | ﹤0.01% | 1305 |
|
|
2023
Q2 | $2.69K | Hold |
85
| – | – | ﹤0.01% | 1217 |
|
|
2023
Q1 | $3.1K | Hold |
85
| – | – | ﹤0.01% | 1172 |
|
|
2022
Q4 | $2.52K | Hold |
85
| – | – | ﹤0.01% | 1155 |
|
|
2022
Q3 | $3K | Hold |
85
| – | – | ﹤0.01% | 1079 |
|
|
2022
Q2 | $3K | Hold |
85
| – | – | ﹤0.01% | 991 |
|
|
2022
Q1 | $4K | Hold |
85
| – | – | ﹤0.01% | 842 |
|
|
2021
Q4 | $6K | Hold |
85
| – | – | ﹤0.01% | 788 |
|
|
2021
Q3 | $8K | Hold |
85
| – | – | ﹤0.01% | 643 |
|
|
2021
Q2 | $5K | Hold |
85
| – | – | ﹤0.01% | 643 |
|
|
2021
Q1 | $2K | Hold |
85
| – | – | ﹤0.01% | 734 |
|
|
2020
Q4 | $2K | Buy |
85
+5
| +6% | +$90 | ﹤0.01% | 660 |
|
|
2020
Q3 | $1K | Hold |
80
| – | – | ﹤0.01% | 702 |
|
|
2020
Q2 | $1K | Hold |
80
| – | – | ﹤0.01% | 663 |
|
|
2020
Q1 | $1K | Buy |
+80
| New | +$1.3K | ﹤0.01% | 520 |
|
Other funds holding ASTH
VPM
3C
VCM
6CM